Milestones

Find here an overview of all Milestones and status per 1 November 2014

 

WP

Milestone Nº

Milestone title

Due month

status

new date

 

 

WP1

MS1

Consortium agreement has been signed

1

completed

 

WP1

MS9

When the first periodic report is accepted by the EC

16

completed

 

WP1

MS18

When the second periodic report is accepted by the EC

28

completed

 

WP1

MS24

When the third periodic report is accepted by the EC

40

completed

 

WP1

MS36

When the fourth periodic report is accepted by the EC

52

 

 

WP1

MS41

When the fifth periodic report is accepted by the EC

60

 

 

WP1

MS52

When the catalogue of standardized data within European biobanks has been established

24

completed

 

WP1

MS53

When the Year 3 update to catalogue of standardized data within European biobanks has been performed

36

completed

 

WP1

MS54

When the Year 4 update to catalogue of standardized data within European biobanks has been performed

48

 

 

WP2

MS55

When the initial object model and exchange format for phenotype data have been established

12

completed

 

WP2

MS20

When the validated phenotype systems are connected to WP4

36

completed

 

WP2

MS25

DataSHaPER harmonization rules defined and integrated into phenotype system

42

completed

 

WP2

MS26

When the protocols and policies are presented

48

 

 

WP2

MS42

When de datasets from five source biobanks are loaded

42

completed

 

WP2

MS5

Consensus on minimal dataset for each selected complex disease

12

completed

 

WP2

MS56

Initial application ontology for the four selected complex diseases

24

completed

 

WP2

MS57

Pilot phenotype submission, curation, search and presentation systems established

30

completed

 

WP2

MS58

Datasets from five source biobanks loaded

42

completed

 

WP2

MS59

Evaluation of integrated phenotype data system for research

48

 

 

WP3

MS10

DataSHIELD incorporated into OBiBa Pooling Platform

18

completed

 

WP3

MS27

ESPRESSO-forte Study Simulation Platform all enhancements completed

48

 

 

WP3

MS28

When the final results are presented on the BioSHaRE-EU conference

48

 

 

WP3

MS6

ESPRESSO-forte Study Simulation Platform goes live in beta test on P3G Observatory

12

completed

 

WP4

MS14

When the first version modular database system is released [software release cycle 1]

24

completed

 

WP4

MS29

When the second version modular database system is released [software release cycle 2]

48

 

 

WP4

MS39

When the final object models for experiment and molecular data are finished

60

 

 

WP4

MS60

When the initial object models for experiment and molecular data have been established

24

completed

 

WP5

MS15

A set of evidence-based minimal standards for important samples types and measurement techniques is

24

completed

 

WP5

MS21

Completion of analysis on snap frozen samples and samples transported at 4°C or RT for up to 36 hour

36

completed

 

WP5

MS30

When all ethical, legal, and social (ELSI) standards for the use of biospecimen from multiple bioban

48

 

 

WP5

MS40

When the process of harmonisation and standardisation, the strengths of Biobanks in assessing inflam

60

 

 

WP5

MS43

When available inflammatory markers have been evaluated and their measurement compared

48

 

 

WP5

MS44

When laboratory analyses in the field of inflammatory markers have been evaluated

30

delayed

40

WP5

MS45

When different samples sources have been analysed for their quality and interchangebility

30

delayed

40

WP5

MS7

When all existing protocols and SOPs are collected and reviewed

12

completed

 

WP6

MS3

Completion of the catalogue of legacy data.

6

completed

 

WP6

MS31

Presentation of the recommendations for utilization

48

 

 

WP6

MS32

When the ELSI Standards for the use of healthy obese data are agreed upon

48

 

 

WP6

MS46

When the study plan, harmonisation protocols and catalogue of planned new analysis are finalised

21

delayed

48

WP6

MS47

When novel signals for selected phenotypes have been identified

24

delayed

48

WP7

MS22

Methods to be included

36

completed

 

WP7

MS33

Dissemination of results at international conference

48

 

 

WP7

MS34

Publication of results on evaluation of integrated environment and health toolkit

48

 

 

WP7

MS48

When the methods to be included in the environment and health toolkit have been identified

12

completed

 

WP7

MS49

When the state of the art report on integrating and analysing cohort data has been finalised

36

delayed

48

WP7

MS50

When a common panel for minerals and trace elements has been developed and analysed

30

completed

 

WP7

MS51

when a Pan-European standard for harmonised and collected inflammation has been delivered

36

delayed

48

WP7

MS64

When results have been disseminated at international conference

48

 

 

WP7

MS8

The most important environmental and life-style related risk factors are identified

12

completed

 

WP8

MS11

Presentation of the consensus report and overview of when to standardize and when to harmonize

18

completed

 

WP8

MS2

When the key initiatives to with which BioSHaRE-EU will interface are identified

3

completed

 

WP8

MS37

Final meeting at 54 months and produce an overview report is finished

54

 

 

WP8

MS38

When the final dissemination report is distributed

60

 

 

WP8

MS4

Completion of a strategic integration plan for systematic and regular inter-project communication

8

completed

 

WP8

MS65

Meeting at 6 months with relevant projects

6

completed

 

WP8

MS66

Meeting at 12 months with relevant projects

24

completed

 

WP8

MS67

Meeting at 18 months with relevant projects

18

completed

 

WP8

MS68

Meeting at 24 months with relevant projects

24

completed

 

WP8

MS69

Meeting at 30 months with relevant projects

30

completed

 

WP8

MS70

Meeting at 36 months with relevant projects

36

completed

 

WP8

MS71

Meeting at 42 months with relevant projects

42

completed

 

WP8

MS72

Meeting at 48 months with relevant projects

48

 

 

WP8

MS73

Meeting at 54 months with relevant projects

54

 

 

WP8

MS74

Preliminary meeting on standardization versus harmonization

15

completed

 

WP9

MS12

Completion of a catalogue of resources in P3G, BBMRI and large consortia

18

completed

 

WP9

MS16

When the complete design of causal analysis project is finished

24

completed

 

WP9

MS17

When all studies to be included are identified and have been invited

24

completed

 

WP9

MS19

When the complete design of disease risk prediction project is finished

30

completed

 

WP9

MS23

Completion of full harmonization of projects and any additional work required

36

completed

 

WP9

MS35

Presentation of ELSI tools for standardization and harmonisation

48

 

 

WP9

MS75

Studies to be included identified and invited to join

24

completed

 

WP9

MS76

When is determined whether additional tools need to be developed

36

completed